Candidate Lassa fever vaccine enters human trials as global health partners outline plans for Nigeria

A candidate vaccine for Lassa fever has entered its first human trials in the United Kingdom, raising hopes for improved prevention of a disease that continues to cause recurrent outbreaks annually in Nigeria and across West Africa. The development was disclosed during an interview with PREMIUM TIMES involving global health officials...